OVERVIEW

Community Practice Connections™: 3rd Annual New York Cardio-Endo-Renal Collaborative (NY CERC) is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 3, 2019
Expiration Date: December 3, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Activity Overview:
The increasing prevalence of cardiometabolic risk continues to be a major challenge for health care providers in the United States because they are currently not managed adequately in clinical practice. With the increase in the number of patients presenting with obesity, diabetes, and hypertension, there has been a parallel rise in the incidence and prevalence of cardiometabolic complications. Cardiometabolic risk incorporates a collection of risk factors that predispose individuals to cardiovascular disease. These risk factors involve multiple pathways and physiologic systems and point to a need for a comprehensive management approach. As a number of cardiometabolic risk factors begin to emerge, patients begin to develop additional subclinical conditions that are discovered only when evaluating the entire constellation of risk factors, thereby enabling clinicians to recommend optimal treatment to prevent cardiovascular and metabolic morbidities.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Discuss clinical strategies for evaluation and diagnosis of patients presenting with cardiac, endocrine, and renal disease.
• Evaluate the rationale behind current and emerging testing used in the stratification of cardiometabolic risk in order to optimize the use of current and emerging agents or therapeutic strategies.
• Recognize and devise strategies to manage treatment-related adverse events and side effects in the care of patients with cardiac, endocrine, and renal disease.
• Discern the potential clinical impact of recent clinical trial data on management of cardiac, endocrine, and renal disease.
• Identify current strategies and recent advancements in the prevention of cardiometabolic disorders.
• Assess barriers to care of patients with cardiac, endocrine, and renal disease.
• Employ strategies for patient counseling to improve education, preventive practices, adherence, and self-management.

Benefits of Participating:
• Gain insights into importance of screening and early detection of cardiometabolic risk factors for early efficacious management to prevent irreversible cardiovascular damage
• Improve competence regarding the integration of novel and newly approved therapies in the management of cardiovascular, renal, and metabolic diseases
• Increase awareness of strategies for overcoming barriers to multidisciplinary care of patients with cardiac, endocrine, and renal disease